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Abstract
The comprehensive identification of functional transcription factor binding sites (TFBSs) is an important step in
understanding complex transcriptional regulatory networks. This study presents a motif-based comparative approach,
STAT-Finder, for identifying functional DNA binding sites of STAT3 transcription factor. STAT-Finder combines STAT-Scanner,
which was designed to predict functional STAT TFBSs with improved sensitivity, and a motif-based alignment to minimize
false positive prediction rates. Using two reference sets containing promoter sequences of known STAT3 target genes,
STAT-Finder identified functional STAT3 TFBSs with enhanced prediction efficiency and sensitivity relative to other
conventional TFBS prediction tools. In addition, STAT-Finder identified novel STAT3 target genes among a group of genes
that are over-expressed in human cancer cells. The binding of STAT3 to the predicted TFBSs was also experimentally
confirmed through chromatin immunoprecipitation. Our proposed method provides a systematic approach to the
prediction of functional TFBSs that can be applied to other TFs.
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Introduction
The ability of any biological system to properly respond to
stimuli heavily depends on biochemical cascades of signaling
pathways that culminate in the activation of transcription factors
(TFs) and the subsequent alteration of gene expression patterns
[1]. Information about which genes need to be expressed in a
specific cell type at any given time is believed to be encoded in the
genome. The molecular machinery used to interpret such genetic
information has evolved to ensure the accuracy and specificity of
gene regulation. Transcription is a multi-step process requiring the
concerted action of many proteins. Transcriptional activators and
repressors bind in a sequence-specific manner to promoters or
enhancers of target genes. They govern the recruitment of trans-
activators, chromatin modifiers, and general transcription factors,
including RNA polymerase II, to regulate gene expression [2,3].
Whole genome approaches to measure genome-wide expression
patterns have divulged groups of genes that are co-regulated to
exert spatially and temporally controlled cellular responses [4].
Identifying the responsible regulatory modules that govern the
coordinated actions of combinatorial transcription factors is
crucial for understanding the regulatory circuits of biological
processes [5]. For this purpose, computational tools have been
developed to aid in the identification of transcription factor
binding sites (TFBSs) in the promoters of the co-regulated genes
[6,7,8]. These computational approaches can be divided into two
classes: (1) pattern detection and (2) pattern matching. Pattern
detection, also known as de novo motif discovery, finds putative
binding sites for unknown TFs that are over-represented in the
promoters of co-regulated genes. If the binding specificity of a TF
is already known, pattern matching methods are preferred [9]. In
the pattern matching approach, DNA sequence information of
TFBSs is expressed as a position weight matrix (PWM), which can
be used to score potential regulatory sites within a statistical
framework [10]. However, because DNA binding sites for TFs are
generally short and degenerate, this method is prone to high false
positive prediction rates [11].
Based on the observation that conserved non-coding DNA
sequences are often important for the regulation of biological
functions, cross-species sequence comparisons have been actively
integrated to distinguish functional and non-functional TFBSs
[12,13,14]. The act of incorporating the evolutionarily conserved
sequence information in the regulatory regions filters out the non-
conserved TFBSs, thereby greatly reduce the false positive prediction
rate [15,16,17,18,19]. Although this approach has been successfully
applied to increase the predictive power of motif finding, it is highly
sensitive to the algorithm used for sequence alignment and the
accuracy of annotated transcriptional start site (TSS) information.
Therefore, it has been reported that sequence-based promoter
alignments often fail to detect short or degenerate regulatory elements,
when evolutionary divergent promoter sequences are aligned [12,17].
To overcome these limitations, an alignment-free algorithm based on
network-level conservation has also been suggested [20].
Signal transducer and activator of transcription 3 (STAT3)
belongs to the STAT family of transcription factors, which is
activated by Interleukin-6 (IL-6) and related cytokines, such as
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e6911IL-10, Oncostatin M (OSM), and leukemia inhibitory factor (LIF)
[21]. Thus far, seven mammalian STATs (1, 2, 3, 4, 5a, 5b, and 6)
have been identified. They all possess a DNA binding domain, an
SH2 domain for dimerization, and a C-terminal trans-activation
domain [22]. Upon stimulation with extracellular ligand, activated
STAT3 forms homodimers or heterodimers with another STAT
family member, STAT1, then translocates into the nucleus and
binds to cognate regulatory elements in the promoters of STAT-
responsive genes. Accumulating evidences suggest that STAT3
also associates with other transcription factors to form enhanceo-
some complexes in the promoter regions of target genes and
controls cooperative gene induction [23,24,25]. STAT3 is
involved in diverse cellular responses, including cellular differen-
tiation, survival, stem cell renewal, wound healing and systemic
inflammation; this has been proven by the phenotypes of
genetically modified STAT3 mutant mice [22,26,27,28,29]. It
has been found that STAT3 participates in carcinogenesis, and
that the ectopic expression of a constitutively active form of
STAT3 (STAT3-C) induces tumor formation in nude mice [30].
Furthermore, the expression of constitutively-active STAT3 has
been observed in various types of human cancer including multiple
myeloma, colon, ovary, liver, lung, head, and neck cancers [31].
While the regulatory and general trans-activation mechanisms of
STAT3 have been thoroughly studied, not too much effort has
been made towards the identification of direct target genes of
STAT3. The identification of those target genes is crucial for
mediating the diverse biological effects of STAT3 signaling.
To characterize STAT3-mediated transcriptional programs, we
have developed a computational framework designed to predict
STAT3 TFBSs with improved sensitivity and low false positive
rate. Through the integration of the microarray data obtained
from the STAT3 activation condition and the TFBS prediction
tools, we attempted to identify novel STAT3 target genes. Using
our STAT-Finder program, we identified eight novel STAT3
target genes among a group of genes that are highly expressed in
cancer cells. These were then confirmed through chromatin
immunoprecipitation.
Results
Overview of STAT-Finder
To identify direct STAT3 target genes, we developed a
computational framework that predicts functional TFBSs of
STAT3 with increased sensitivity and low false positive rate.
Our framework, STAT-Finder, was constructed based on two
computational components, a TFBS scanning program (STAT-
Scanner) and a motif-based alignment program (Figure 1). STAT-
Scanner was designed to increase the sensitivity for detecting
functional STAT3 TFBSs. A currently available STAT3-specific
PWM of TRANSFAC database [32], V$STAT3_01, frequently
Figure 1. An overview of STAT-Finder. STAT-Finder has two components: The first module, STAT-Scanner, takes a set of six orthologous
mammalian promoter sequences as input. Each promoter sequence is searched to mark putative TFBSs using the modified 8 STAT-related PWMs.
Binding affinity scores of predicted TFBSs are calculated based on the P-values, and a sequence of affinity scores is generated for each promoter. The
second module progressively aligns the score sequences and calculates posterior probability to evaluate the degree of motif conservation.
doi:10.1371/journal.pone.0006911.g001
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not shown). For improved predictive power, STAT-Scanner was
therefore designed to use combined PWMs of binding specificity
similar to STAT3. Although STAT family members have different
physiologic functions and regulate distinct sets of target genes, the
targets of individual STAT proteins sometimes overlap, and DNA
sequences recognized by STAT family members are similar
[21,22,23].
For unbiased identification of the PWMs that share sequence
similarity with the STAT3-specific PWM, V$STAT3_01, a total
of 565 PWMs derived from vertebrate TRANSFAC database
[32] were clustered based on their motif similarity (Figure S1).
The motif similarity was defined as the P-value of the gapped
alignment between the two PWMs based on the Kullback-Leibler
divergence [33] (See Methods). Total numbers of PWM clusters
increased with stringent P-value cut-off, reaching maximum
cluster numbers of around 10
216 P-value (Figure S1A). With the
P-value cut-off of 10
27, PWMs assigned for the STAT family
members were found in the same cluster. It is noteworthy that
PWM clustering did not reveal any non-STAT PWMs that were
similar enough to include nor were there any STAT PWMs that
were distinctly different (Figure S1B). We chose among them eight
PWMs from the STAT family members with high PWM quality
scores (.0.6), where each quality score was calculated using the
method proposed by Rahmann et al. [34]. The relevance of the
selected PWMs for detecting known STAT3 TFBS has been
evaluated in the previously identified STAT3 target genes [35]
(Figure S2).
To minimize false positive predictions, results from STAT-
Scanner were then analyzed using the comparative motif-based
alignment tool (Figure 1). This method finds conserved binding
sites within the orthologous promoters of six mammalian species
by comparing multiple sequences. Within a probabilistic frame-
work, STAT-Finder then evaluates the posterior probabilities of
TFBSs as predicted by STAT-Scanner by assigning higher prior
probabilities on conserved sites over non-conserved ones.
Validation of STAT-Scanner
We first compared the performance of STAT-Scanner with the
most practical TFBS prediction tools, MATCH 2.7 [36] and
MotifLocator [37]. For this purpose, we collected positive genes
with experimentally proven STAT3 binding sites in their promoter
regions through literature mining and TRED search (http://rulai.
cshl.edu/ TRED) [38]. Resulting information on the 22 reference
sequences are listed in Table S1. Genomic DNA sequences
spanning from 2,000 bp up-stream to 500 bp down-stream of the
annotated TSS of each gene were used as input promoter
sequences. Prediction of the true positive TFBSs was then plotted
as a function of the total predicted TFBS count for different cut-off
values. As shown in Figure 2A, STAT-Scanner, which uses
combined STAT3-related PWMs, outperforms MATCH and
MotifLocator, both of which use the representative STAT3 PWM
(V$STAT3_01). We believe the enhanced predictive power of
STAT-Scanner was partly due to the usage of combined STAT3-
related PWMs, especially since the predictive power of MotifLo-
cator also increased when combined PWMs were used (Figure S3).
We also evaluated the performance of STAT-Scanner using
genome-wide STAT3 binding data obtained using embryonic
stem cells [39]. Among the 461 genes with STAT3 binding peaks
in the 2.5 kb promoter regions, 412 have been accurately
predicted by STAT-Scanner to have at least one STAT3 TFBS
(Figure 2B). The overall performance of STAT-Scanner was better
than those of both MATCH and MotifLocator, as the detection of
the same number of true binding sites was achieved by both with
significantly lower total numbers of predicted sites. Although
MATCH and MotifLocator performed similarly to STAT-
Scanner in detecting about 50% of true STAT3 TFBSs, the latter
outperforms both by accurately predicting the remaining true sites.
We believe this is partly due to the usage of combined STAT-
related PWMs which has the capability to enhance the
performance of MotifLocator, albeit less than the enhancement
for STAT-Scanner, with combined data derived from multiple
PWMs (Figure S4). The relative performance of both methods is
Figure 2. Performance comparison of the STAT3 TFBS prediction tools. Curves for the changes of the number of true positive TFBSs
detected using MotifLocator (V$STAT3_01), MATCH (V$STAT3_01), or STAT-Scanner, as a function of total number of predicted TFBSs (A) in the
reference set of 22 STAT3 target genes (Table S1) and (B) in the genome-wide STAT3 ChIP-Seq dataset [39].
doi:10.1371/journal.pone.0006911.g002
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the fact that their scores on the predicted sites are not directly
comparable among different PWMs, thus showing the importance
of our scoring scheme in integrating matches to different PWMs.
These results also indicate that overlapping PWMs with similar
binding specificity are critical to the development of improved
strategies to detect functional TFBSs of STAT3 with high
predictive accuracy.
Features of the functional STAT3 TFBS
The ultimate goal of computational prediction is to detect
functional TFBSs with a high degree of confidence. To filter out
the false positive TFBSs with high affinity scores, we examined
various functional constraints such as evolutionary conservation
and genome structure of predicted STAT3 TFBS regions.
Sequence conservation among multiple species has been proven
to constrain functional TFBS [16,17,40]. Therefore, we first
evaluated the distribution of multispecies conservation scores
(PhastCons score) [41] and regulatory potentials (RegPotential
score) [42] for positions in the functional and non-functional
STAT3 TFBSs detected by STAT-Scanner using the reference set
of 22 genes (Table S1). For convenience, we considered a TFBS
functional if it was supported by experimental STAT3 binding
data; otherwise, the TFBS was considered non-functional. The
distribution of PhastCons scores for the non-functional STAT3
TFBSs were skewed towards zero, while PhastCons scores for
about 50% of the functional STAT3 TFBS exceeded 0.1
(Figure 3A). In contrast, the distribution of RegPotential scores,
which measure the similarity of patterns to those in the known
regulatory elements, was similar for positions of the functional and
non-functional STAT3 TFBSs (Figure 3B). Next, we investigated
the methylation-resistant CpG island features of the STAT3
TFBS-containing regions. Over-representation of the binding
sequences for specific transcription factors, such as zinc-finger
proteins, in CpG islands has been previously reported [43]. Most
of the predicted STAT3 TFBSs are located inside CpG islands
[44], but the genomic distribution is not significantly altered
among the functional and non-functional STAT3 TFBSs
(Figure 3C). Repeat elements [45] in the genomic sequence might
compromise the functions of transcription factors, as none of the
functional STAT3 TFBSs have been identified inside the repeated
regions (Figure 3D). In summary, motif conservation, a major
constraint that distinguishes between functional and non-function-
al STAT3 TFBSs, has therefore been included in STAT-Finder.
Validation of STAT-Finder
We next evaluated the performance of STAT-Finder compared
to other comparative methods, namely, EEL [46] and CONREAL
[12]. Given that EEL performs pair-wise alignment based on the
matches to a single PWM, we compared the performance of EEL
using each PWM (V$STAT3_01 and V$STAT1_01) separately.
Meanwhile, the performance of CONREAL was examined by
combining both PWMs. We tested the prediction accuracy of
STAT-Finder in the two positive data sets with STAT3 bindings.
STAT-Finder exhibited better performance compared to EEL
using V$STAT3_01, EEL using V$STAT1_01, or compared to
CONREAL in predicting true STAT3 TFBSs in the 22 previously
identified positive genes (Figure 4A). Note that both EEL and
CONREAL failed to detect about 40–60% of true positive STAT3
sites even at the minimum cut-off value, while STAT-Finder found
all of these. These data indicate that STAT-Finder showed better
performance in terms of finding true positive STAT3 TFBSs that
the other comparative programs missed. It was made more evident
when we searched STAT3 TFBSs using EEL or CONREAL in
the data sets with genome-wide STAT3 binding. Although the
overall performance of the STAT-Finder was similar to EEL in
detecting 56% of true STAT3 TFBSs, only STAT-Finder was
capable of detecting the remaining 30% of the true sites
(Figure 4B). Our data suggest that the improved sensitivity of
STAT-Finder could be attributed to the usage of combined
STAT-related PWMs, which evidently overcame the performance
limitations of V$STAT3_01.
We next attempted genome-wide prediction of STAT3 binding
in the human promoter regions. For this purpose, we first
estimated the cut-off value of the motif conservation score (MCS)
to identify conserved functional STAT3 TFBSs. The degree of
conservation of the predicted TFBS, which was determined by
calculating MCS, was integrated with the affinity scores by STAT-
Scanner (See Methods). The confidence score at each MCS was
evaluated using the 2.5 kb promoter sequences of all annotated
human genes and orthologous mouse genes. The confidence score
determines the probability that a given TFBS is not conserved by
chance. As cut-off values of MCS increased, the total number of
predicted STAT3 TFBSs decreased at a slower rate than the
average number of aligned instances of control motifs, resulting in
escalated confidence scores at MCS values higher than 0.9 (Figure
Figure 3. Score distribution of the functional vs. non-functional
STAT3 TFBSs as predicted by STAT-Scanner. (A) PhastCons score,
(B) Regulatory Potential score, (C) Percentage in the CpG island, and (D)
Percentage in the Repeat region.
doi:10.1371/journal.pone.0006911.g003
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STAT3 TFBSs in the human promoter regions. Among the 15461
human genes with identified orthologs in the mouse, about 7600
genes were predicted to have putative STAT3 binding sites within
the 2.5 kb promoter region, at the probability threshold of 0.9.
Significant enrichment of STAT3 TFBSs could be predicted at the
proximal upstream regions of TSS using STAT-Scanner and
STAT-Finder [35,39] (Figure S6).
Identification of novel STAT3 target genes in the cancer
cells
Constitutive activation of STAT3 and over-expression of its
target gene have been suggested to play critical roles in human
carcinogenesis [12,31,47,48,49,50]. To determine whether or not
STAT-Finder is useful in identifying novel STAT3 target genes,
we applied this program to a group of genes that are over-
expressed in human cancer cells. We integrated microarray data
obtained from the expression module map of genes up-regulated
in cancer [51] and data derived from the A549 cells over-
expressing a constitutively active form of STAT3 [52].
Among the 33 genes that are commonly up-regulated, eleven
have already been reported to be regulated by STAT3 (Table 1).
Using this group of genes, we examined whether or not STAT-
Finder could detect experimentally proven STAT3 TFBSs. It is
noteworthy that we were able to analyze only a fraction of the
promoter sequences, mainly due to alternative promoter usage and
the poorly annotated TSS information available. STAT-Finder
detected three putative STAT3 binding sites in the JUNB
promoter region including one site that has previously been
reported to be a STAT3 binding site [53] (Figure 5A). Using three
different cell lines derived from human cancer patients, we
confirmed STAT3 binding to the JUNB promoter by chromatin
immunoprecipitation (Figure 5B). STAT-Finder also successfully
detected one STAT3 TFBS in the Nicotinamide N-methyltrans-
ferase (NNMT) promoter region, a recently identified STAT3
target gene [54] (Figure 5C, D). Interestingly, STAT-Finder was
unable to detect known STAT3 TFBS in the MYC promoter
region (Figure 5E), even though MYC has been reported to be a
STAT3 target [55]. It has also been reported that STAT3 binding
to the promoter region of the MYC gene requires a site that is
different from the consensus STAT3 binding sequences, but is
similar to E2F TFBS, indicating that, in this case, STAT3 binding
depends on the presence of other transcription factors [55]. Using
primer sets that detect known STAT3 binding sites in the MYC
promoter, we were able to confirm its binding upon IL-6
stimulation in HepG2 cells (Figure 5F). These results suggest that
STAT-Finder could efficiently detect binding sites for STAT3 only
if their binding does not depend on the presence of other cis or
trans factors.
We next examined whether or not we can identify novel target
genes of STAT3 using STAT-Finder. For this purpose, we selected
genes with conserved TSS (Table 1) and determined the presence
of putative STAT3 TFBSs using STAT-Finder in their promoter
regions. STAT-Finder successfully detected putative STAT3
TFBSs with high probabilities in the promoter regions of AKAP12
(A-kinase anchoring protein 12), HIC2 (hyper-methylated in
cancer 2), and THBS1 (Thrombospondin 1). STAT3 binding to
these predicted sites was experimentally confirmed by ChIP assay
(Figure 6A–F). To verify the specificity of STAT-Finder, we also
assayed the binding of STAT3 to the sites that were not conserved,
but were present in the promoters of human orthologous genes. In
contrast to the conserved STAT3 TFBSs, we could not detect
STAT3 binding to the non-conserved STAT3 TFBSs in human
cancer cell lines (Figure 6G). STAT3 binding to other predicted
STAT3 TFBSs present in the promoter regions of ATF3
(activating transcription factor 3), DUSP5 (dual specificity
phosphatase 5), SERPINE1 (serpin peptidase inhibitor, class E),
NP (nucleoside phosphorylase), and SLC2A3 (solute carrier family
2, facilitated glucose transporter, member 3) were also experi-
mentally validated (Figure S7). Finally, we studied whether or not
other computation tools such as EEL or CONREAL could also
accurately detect STAT3 target sites that have been identified and
validated in this study. Of 10 promoter sequences containing
experimentally proven 10 STAT3 binding sites (Figure 5, 6 and
Figure 4. Performance comparison of the comparative alignment tools. Curves for the changes of the number of true binding sites detected
using EEL (V$STAT3_01 or V$STAT1_01), CONREAL (All; combined PWMs of V$STAT3_01 and V$STAT1_01), or STAT-Finder, as a function of total
number of predicted TFBSs (A) in the reference set of 22 genes (Table S1) and (B) in the genome-wide STAT3 ChIP-Seq dataset [39].
doi:10.1371/journal.pone.0006911.g004
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including all of the 10 experimentally validated STAT3 binding
sites. Meanwhile, EEL and CONREAL detected only 5 (50%) and
2 (20%) validated STAT3 binding sites among 23 and 6 total
predictions, respectively, thereby indicating that STAT-Finder has
better performance in terms of identifying novel target genes of
STAT3 (Figure S8).
Discussion
We presented a computational framework for identifying
functional STAT3 TFBSs in mammalian promoters. The first
compartment, STAT-Scanner, was designed to predict function-
al STAT3 TFBSs with improved sensitivity. By using compar-
ative motif-based alignments, STAT-Scanner was linked to
STAT-Finder to minimize false positive predictions. Our
proposed method was tested using previously identified STAT3
target genes and was successfully applied to the identification of
novel target genes.
Our strategy in developing STAT-Finder relied on several
assumptions. First, the DNA binding specificity of STAT3 is
shared by other STAT family members. STAT transcription
factors bind to similar DNA sequences, and the similar DNA
binding specificity of various STAT transcription factors, such as
STAT1, STAT5A/5B, or STAT6, have been experimentally
proven [56]. It has also been noted that integration of the
overlapping matches detected by matrices from the same family
members greatly reduces the number of total predicted TFBSs,
and hence decreases the rate of false positive detection [57].
Furthermore, it has been recently reported that roughly half of
Table 1. Putative STAT3 target genes.
Gene Entrez ID
aFold Change
(log2)
aFDR
bCancer
Module #
bCancer Module
(P-value)
Reported STAT3
regulation
Reported
STAT TFBS
cReference
Remark for
experiment
AKAP12 9590 3.955 0 3 ,1e-14 - - - Putative target
ATF3 467 5.885 0 197 0.002153 - - - Putative target
CCL2 6347 7.205 0 3 ,1e-14 ++ [73]
CITED2 10370 2.911 0 3 ,1e-14 ++ [74]
CXCL2 2920 2.092 0 197 0.021719 + -[ 7 5 ]
DDEF2 8853 2.184 0 98 1.05E-12 + -[ 7 6 ]
DUSP5 1847 2.782 0 98 0.001713 - - - Putative target
ETS2 2114 3.039 0 197 0.000899 - - -
FOSL1 8061 4.032 0 98 7.13E-05 - - -
HIC2 23119 2.817 0 17 0.007665 - - - Putative target
JUN 3725 3.194 0 197 5.36E-05 + -[ 7 7 ]
JUNB 3726 2.436 0 17 1.07E-05 ++ [53] Positive control
LDLR 3949 3.548 0 3 ,1e-14 - - -
LOXL2 4017 2.139 0 3 ,1e-14 - - -
MAFF 23764 5.273 0 3 ,1e-14 ++ [78]
MAP2K3 5606 2.739 0 18 0.001053 - - -
MYC 4609 2.053 0 126 ,1e-14 ++ [55] Positive control
NNMT 4837 2.041 0 3 ,1e-14 ++ [54] Positive control
NP 4860 2.043 0 3 ,1e-14 - - - Putative target
NPC1 4864 5.916 0 18 1.1E-06 - - -
PLAUR 5329 2.89 0 3 2.53E-12 - - -
PLEC1 5339 2.982 0 18 0.016729 - - -
PLEKHC1 10979 2.188 0 3 0.045975 - - -
PMAIP1 5366 2.031 0 54 1.7E-05 + -[ 7 9 ]
PXN 5829 2.217 0.098 18 5.01E-06 - - -
SERPINE1 5054 2.312 0 3 ,1e-14 - - - Putative target
SGK 6446 2.826 0 3 0.004895 ++ [80]
SLC2A3 6515 6.191 0 17 2E-06 - - - Putative target
TAF1A 9015 2.661 0.042 124 0.005465 - - -
THBS1 7057 3.25 0 3 ,1e-14 - - - Putative target
UGCG 7357 6.265 0 3 2.21E-08 - - -
WEE1 7465 2.172 0.069 57 ,1e-14 - - -
ZYX 7791 2.124 0 3 ,1e-14 - - -
aAnalyzed microarray data of A549 cell line over expressing STAT3C [52] using SBEAMS [72].
bAnalyzed data of the cluster in the Cancer Module Map [51] (http://robotics.stanford.edu/,erans/cancer/).
doi:10.1371/journal.pone.0006911.t001
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conventional motif scanning approach using a single PWM for
each TF has an intrinsic limitation in detecting all functional
TFBSs. As a result, the predictive power of STAT-Scanner was
significantly enhanced by integrating STAT-related PWMs. The
second assumption, used in the motif-based alignments, is that the
relative locations of functional TFBSs are conserved among closely
related mammalian species. In yeast, highly conserved TFBSs for a
set of TFs exhibit relatively low spatial deviations (,150–200 bp)
[20]. Likewise, we found that, for six mammalian species, known
STAT3 TFBSs are located within a similar spatial distribution on
each promoter.
Figure 5. Experimental validation of STAT3 binding to the known STAT3 TFBSs. (A,C,E) The affinity score from STAT-Scanner (top) and the
posterior probability from STAT-Finder (middle) of predicted STAT3 are plotted in the sliding windows for a 2.5-kb promoter region across the JUNB
(A), NNMT (C), and MYC (E) genomic loci. The open square at bottom indicates the predicted TFBS with the posterior probability higher than 0.95;
while the asterisk (*) in the promoter region depicts the known STAT3 TFBS. (B, D, F) Chromatin immunoprecipitation analysis with an anti-STAT3
antibody: Reported STAT3 TFBSs of JUNB (B), NNMT (D), and MYC (F) were PCR amplified using the primers specific binding sites (*) from the input and
immunoprecipitated cell lysates, derived from the non-stimulated or IL-6 (10 ng/ml) + IL-6sR (10 ng/ml)-stimulated HepG2, A549, and MDA-MB-231
cells.
doi:10.1371/journal.pone.0006911.g005
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PLoS ONE | www.plosone.org 7 September 2009 | Volume 4 | Issue 9 | e6911Figure 6. Experimental validation of STAT3 binding to the novel STAT3 TFBSs. (A, C, E) The affinity score (top, STAT-Scanner) and posterior
probability (middle, STAT-Finder) of predicted STAT3 TFBSs are plotted in the sliding windows for a 2.5-kb promoter region across the AKAP12 (A),
HIC2 (C), and THBS1 (E) genomic locus. The closed square at the bottom indicates the predicted TFBS with posterior probability .0.5; while the yellow
square shows the predicted TFBS with no conservation. (B, D, F) ChIP analysis with an anti-STAT3 antibody. Putative STAT3 TFBSs of the AKAP12 (B),
HIC2 (D), and THBS1 were PCR amplified using the primer sets indicated by inverse arrows. (G) ChIP analysis with an anti-STAT3 antibody. Predicted
TFBSs with no conservation in the human AKAP12, HIC2, and THBS1 genes were PCR amplified using the primer sets indicated by inverse arrows.
doi:10.1371/journal.pone.0006911.g006
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genes that are over-expressed in human cancer cells. Likewise,
STAT3 binding to the predicted TFBSs has been experimentally
verified in IL-6 stimulated human cancer cell lines. Interestingly,
STAT3 was recruited to the predicted TFBS in a cell type-specific
manner. For example, STAT3 binding to the predicted TFBSs in
the promoter regions of the AKAP12 and HIC2 genes was observed
in un-stimulated but not in IL-6 stimulated A549 and MDA-MB-
231 cells.However, in the HepG2 cells,STAT3 wasrecruitedto the
same TFBS only after IL-6 stimulation (Figure 6). In contrast,
STAT3 binding to the promoter regions of MYC, SERPINE1, NP,
and SLC2A3 was only detectable in IL-6 stimulated HepG2 cells,
but not in A549 or MDA-MB-231 cells (Figure 6, Figure S7).
Furthermore, it is evident that STAT3 binding to the predicted
TFBSs in the promoters of the candidate target genes does not
guarantee the expression of that gene. Although the expression of
most of the target genes had been altered upon STAT3 binding to
the promoter, we found that STAT3 binding to target sites did not
always correlate with gene expression in the cell lines tested (Oh,
YM, unpublished data). This suggests that STAT3 binding to target
sites is not sufficient in inducing gene expression, and tissue-specific
transcription factors, or trans-activators that specifying modification
in the chromatin region may also be required [59,60,61,62].
A cis-regulatory module comprises a cluster of multiple TFBSs
that cooperatively-interact with TFsto controlgene expression. The
identificationof cis-regulatory modules for specific gene regulation is
a challenging step towards understanding genome-wide transcrip-
tion regulatory networks in mammalian genomes. Therefore, it is
necessary to efficiently predict functional TFBSs for individual TFs.
We expect that our comparative approach can be applied to other
TFs with some restrictions. First, the efficiency of our program
depends on the degree of evolutionary conservation among the six
mammalian species. Therefore, DNA binding sites for TFs engaged
in species-specific gene regulation may not be predicted. It is
noteworthy that the frequent gain or loss of TFBSs in the intergenic
regions leads to the evolution of transcriptional circuits [63].
Second, our program may not be applied to TFs that rely on other
DNA binding proteins for recruitment into DNA. Third, because
we only compared 2 kb of upstream promoter sequence relative to
the annotated TSS, DNA binding sites of TFs that are enriched in
regions distal to the TSS might be overlooked by our program.
Although cis-regulatory regions that lie .100 kb away from the
TSS exist, it has been suggested that most functional TFBSs are
highly enriched in regions proximal to the TSS [40,64]. Another
limitation is the amount and quality of annotated TSS information
obtained from diverse mammalian species. With the exception of
those from humans and mice, annotated TSS information for most
of the mammalian genomes is not available, and correct TSS
information is crucial for the identification of evolutionarily
conserved TFBSs based on motif-based alignments. Obtaining
accurate and reliable prediction of functional TFBSs in the
promoter region is a critical step in deciphering the regulatory
code of the complex transcription regulatory networks that govern
diverse biological responses. Given that our proposed method is
based on a multiple-motif model, we believe it can be applied to
other TFs, with some modifications, and may serve as a basic tool to
discover important cis-regulatory features.
Materials and Methods
Clustering of STAT3-related PWMs
We used dynamic programming to find the optimal ga-
pped alignment between two PWMs. We denote by H1 [ R
W1|4,
H2 [ R
W2|4 thetwoPWMsoflengthW1,W2 over S~ A,C,G,T fg
to align, where H
T
k,w represents row w, each entry is non-negative
and
P 4
l~1
Hk,wl~1. The optimal pair-wise alignment can be found by
the following steps. We first construct a matrix F[R
(W1z1)|(W2z1)
whose pz1, qz1 ðÞ -element F pz1, qz1 ðÞ is the score of the
optimal alignment between the sub-matrices H
T
1,1:p and H
T
2,1:q.
Initially, we set F 1,1 ðÞ ~0, F pz1,1 ðÞ ~pd and F 1,qz1 ðÞ ~qd for
allp,q,wh er ed isa gappenalty.Wethen buildup the matrix F using
the following recurrence:
Fp z1, qz1 ðÞ ~max
Fp ,q ðÞ zs H
T
1,p,H
T
2,q
  
,
Fp ,qz1 ðÞ zd,
Fp z1,q ðÞ zd
8
> > <
> > :
where s H
T
1,p,H
T
2,q
  
is the match score which is defined by the
Kullback-Leibler divergence
s H
T
1,p,H
T
2,q
  
~2exp {KL H
T
1,pjH
T
2,q
    
{
1
2
where
KL H
T
1,pjH
T
2,q
  
~{
X 4
l~1
H
T
1,pl log
H
T
2,ql
H
T
1,pl
 !
:
To define the similarity between the two PWMs, we assessed the
optimal alignment by calculating the P-value. The P-value of the
observed alignment score was calculated by estimating the score
distribution of 1000 randomly-permuted PWMs via the Gaussian
distribution. In this study, the gap penalty d was set to 0.5.
Prediction of putative STAT TFBSs: STAT-Scanner
We searched putative TFBSs of the STAT family in input
promotersequencesandevaluatedtheirbindingaffinityscoresusing
STAT-Scanner. Given a set of position count matrices obtained
from TRANSFAC9.4[32],wereconstructedSTAT-relatedPWMs
to compute the P-values of the match scores using a method for
calculating the exact distribution of scores [65,66]. Briefly, our
method consists of three steps. First, we transformed each position
count matrix into the corresponding position frequency matrix
(PFM) by adding position-dependent pseudo-counts [34]. This
position specific regularization leaves the conserved positions of the
matrix relativelyunchanged.Second, fromtheregularized PFM,we
reconstruct a position weight matrix (PWM) whose element is the
log-oddsscorebetween the PFMand background model,definedby
a zero-order Markov chain. Then, the match score is defined by the
sum of the log-odds scores. To account for the effect of the uneven
distribution of ‘‘GC’’ and ‘‘AT’’ content, we used six different
background models that were constructed based on clusters of
nucleotide compositional vectors of the whole mouse promoter
sequences available from Ensembl [67]. For clustering, we used the
k-means clustering algorithm. Finally, to determine statistically
significantTFBSs,we calculatedtheexactdistributions ofthematch
scores under the background model assumption. From the
distributions, we calculated the type-I sequence error probability
an(s), which measures the probability that at least one site within a
sequence of length n (n=500 as proposed by [34]) has a match score
larger than or equal to s, under the assumption that the sequence is
generated from the background model. We then converted the
match score, s, into the affinity score, t, defined by 1- an(s). This
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score withina statistical hypothesis testing framework. In addition, it
is also plausible to directly compare the affinity scores of different
STAT-related PWMs.
Given a set of STAT-related PWMs and an input promoter
sequence, STAT-Scanner first computes the nucleotide composi-
tion of the input sequence in order to select the nearest background
model, and searches TFBSs whose affinity scores are larger than the
threshold, with the PWMs constructed by the chosen background
model. We used eight STAT-related PWMs, V$STAT_01,
V$STAT1_01, V$STAT3_01, V$STAT5A_01, V$STAT5B_01,
V$STAT5A_02, V$STAT1_02, and V$STAT_Q6, and combined
all overlapping sites of the eight PWMs into one with the maximum
affinity score. Notably, the max operator is applicable because the
affinity scores of different PWMs are directly comparable.
Prediction of the conserved STAT TFBSs: STAT-Finder
STAT-Finder was designed to minimize the false positive
discovery of predicted TFBSs using comparative sequence
comparisons. It searches conserved sites within the promoters of
six orthologous species by sequences of affinity scores. To diminish
probabilities of misalignments, we used score sequences defined by
STAT-Scanner as a first approximation of the conserved
regulatory regions. We regarded a region with nonzero affinity
scores within the score sequence as the regulatory region. We focus
on the regulatory regions of multiple alignments by ignoring the
non-conserved regions. We progressively aligned the six score
sequences obtained from orthologous promoter sequences,
according to the phylogenetic tree of all six mammalian species,
and evaluated the degree of conservation by calculating the Motif
Conservation Score (MCS). The MCS value of an aligned TFBS
ranges from 0 (non-conserved) to 1 (most conserved).
Motif-based alignment tool consists of two main parts to align
multiple sequences with different affinity scores of STAT TFBSs.
The first part is a pair-wise global alignment module that finds an
optimal alignment between two sequences. We adapted a variant
version of the Needleman-Wunsch algorithm [68], with a
modification in the scoring function for the match between two
affinity scores. The second part is a progressive alignment module
that determines a multiple motif alignment among orthologous
promoter sequences derived from six mammalian species. The
basic concept of this approach is to sequentially perform pair-wise
alignments between two sequences of affinity scores, between a
sequence and a profile, or between two profiles, according to the
phylogenetic tree of the six species. The profile is a set of aligned
sequences with gaps. This progressive alignment efficiently aligns
multiple sequences with reasonable accuracy. In the given multiple
motif alignment, we computed the motif conservation score (MCS)
at each aligned position by taking the average of the aligned
affinity scores. The affinity score of the gap was set to zero and the
‘‘N’’ character was not considered when calculating the average.
STAT-Finder has a unique feature that detects not only
conserved binding sites but also non-conserved ones with very
strong binding signals to rectify the unavoidable alignment error.
Before describing our probabilistic model, we first explain our
notations to define our model. Among the 8 STAT3-related
PWMs, we denote by Hk [ R
W|4 the k
th PWM of length W over
S, where H
T
k,w represents row w, each entry is non-negative and
P 4
l~1
Hk,wl~1. The background model h0 [ R
4, which describes
frequencies over the alphabet within non-binding sites, is defined
by a zero-order Markov chain. We assume the background model
is known in advance and estimated from the whole mouse
promoter sequences.
Suppose we have a promoter sequence Si which is a string of
length L over the alphabet S. In order to allow for multiple
binding sites per sequence, we represent the sequence Si as a set of
overlapping subsequences SW
ij ~ Sij,Sij z1 ðÞ ,...,Sij zW{1 ðÞ
  
of
length W starting at position j [ IW
i , where Sij denotes the letter
at position j and IW
i ~ 1,...,L{Wz1 fg . Let us introduce a
latent variable matrix Zk
i [ R
2|jIW
i j in which the j
th column vector
Zk
ij is defined as a 2-dimensional binary random vector
Zk
ij1,Zk
ij2
hi T
such that Zk
ij~ 0,1 ½ 
T if a binding site of the k
th
PWM starts at position j [ IW
i . Otherwise, Zk
ij~ 1,0 ½ 
T.
Our probabilistic model has the following specification for
defining the joint distribution. First, latent variables Zk
ij indicating
the starting positions of binding sites of the k
th PWM are governed
by the probability p~ p1,p2 ½ 
T such that p1,p2§0 and p1zp2~1.
The prior probability of Zk
ij is specified by
PZ k
ijjp
  
~ P
2
m~1
p
Zk
ijm
m :
For each latent position Zk
ij, the probability distribution of the
subsequence SW
ij is given by
PS W
ij jZk
ij,Hk,h0
  
~PS W
ij jh0
   Zk
ij1
PS W
ij jHk
   Zk
ij2
where
PS W
ij jHk
  
~ P
W
w~1
P
4
l~1
H
1 l,Sij zw{1 ðÞ ðÞ
k,wl
PS W
ij jh0
  
~ P
W
w~1
P
4
l~1
h
1 l,Sij zw{1 ðÞ ðÞ
0l
where 1 l,Sij zw{1 ðÞ
  
is an indicator function which is 1 if
Sij zw{1 ðÞ ~l, and 0 otherwise.
The objective of probabilistic inference in our model is to calculate
the posterior probability PZ k
ijjSW
ij ,Hk,h0
  
because this probability
evaluates the degree of being a true binding site of the subsequence
using our prior knowledge and given data. The posterior probability
can be obtained by using Bayes’ theorem
PZ k
ij2jSW
ij ,Hk,h0
  
~
PS W
ij jHk
  
p2
PS W
ij jh0
  
p1zPS W
ij jHk
  
p2
:
The degree of conservation of each subsequence can be easily
incorporated into our probabilistic framework by assigning
relatively higher prior probability p on Zk
ij than non-conserved
one. In this work, we used the following settings: p2~0:0002 for
non-conserved subsequence (the expected number of binding sites
is 1 when the promoter sequence is 2500 (double stranded)) and
p2~0:01|MCS. The eight different posterior probabilities of the
eight STAT3-related PWMs across the latent positions are
integrated by taking the maximum value and the probability
cutoff value was set to 0.5.
Motif-based pair-wise alignment
We denote two promoter sequences of lengths mi and mj by
tj~t
j
1t
j
2    tj
mj and tj~t
j
1t
j
2    tj
mj, where ti
k and t
j
l are the affinity
scores of STAT3 TFBSs. If the score is smaller than a threshold c,
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corresponding site contains the ambiguous ‘‘N’’ characters. With
this setting, the optimal pair-wise alignment between ti and tj can
be found by dynamic programming. We first construct a matrix
F [ R
miz1 ðÞ | mjz1 ðÞ whose kz1,lz1 ðÞ -element F kz1,lz1 ðÞ is
the score of the optimal alignment between the segments ti
1    ti
k
and t
j
1    t
j
l. For initialization, we set F 1,1 ðÞ ~0,F kz1,1 ðÞ ~kd
and F 1,lz1 ðÞ ~ld for all kandl, where d is a gap penalty. We
then build up the matrix F using the following recurrence:
Fk z1,lz1 ðÞ ~max
Fk ,l ðÞ zst i
k,t
j
l
  
,
Fk ,lz1 ðÞ zd,
Fk z1,l ðÞ zd
8
> > <
> > :
where st i
k,t
j
l
  
is the sequence match score between ti
k and t
j
l
which is defined by
st i
k,t
j
l
  
~
0i f ti
k~{1o rt
j
l~{1,
ln
1{c
ti
k{t
j
l jj if ti
k{t
j
l
     
     =0,
10 if ti
k{t
j
l
     
     ~0 and ti
k,t
j
lw0,
0:1i f ti
k,t
j
l~0
8
> > > > > > <
> > > > > > :
We construct the optimal alignment by tracing back the choices
that result in the final value of F miz1,mjz1
  
.
Motif-based profile alignment
We denote two profiles of lengths m and n by p~p1p2    pm
and q~q1q2    qn, where pk and qlare the aligned affinity scores
of STAT3 TFBSs constructed from disjoint promoter sequences
indexed by I and J, respectively. The pair-wise profile alignment
can be also found by dynamic programming. The profile match
score sp is defined by the average of the sequence match score:
sp pk,ql
  
~
1
I jj J jj
X
i[I
X
j[J
st i
k,t
j
l
  
where the sequence match score s is slightly modified to deal with
the gap ‘‘-‘‘ by setting s {,t
j
l
  
~st i
k,{
  
~d and s {,{ ðÞ ~0.I n
this study, the score threshold c and gap penalty d were set to 0.8
and 20.1, respectively.
Estimation of MCS confidence score
To generate randomly shuffled control motifs, we manually
aligned STAT-related PWMs without gaps by looking up the core
regions (TTCCNGGAA). We excluded V$STAT5A_02 (homo-
tetramer) because it was not aligned with other PWMs. The
operation for random permutation was then applied to the aligned
PWMs to generate 100 control motifs. Based on the assumption
that the control motifs should have occurrence rates similar to the
real motif, we selected 42 control motifs that detect similar
numbers of TFBSs in the reference data set (615%). Among them,
we chose 10 motifs that were most dissimilar to V$STAT_01,
based on the inter-motif distance measure (cut-off: 0.25) [69]. The
confidence level at each MCS was then calculated using the
following equation: (the total number of TFBSs of the real motif -
the average number of TFBSs of the control motifs)/the total
number of TFBSs of the real motif. This value represents the
fraction of the number of conserved TFBSs above the ones that
occurred by chance.
Retrieving information for promoter sequence
Human and mouse promoter sequences (22000, +500 bp of
the annotated transcription start sites) were downloaded from
Table Browser of the UCSC genome browser [70]. We used hg18
and mm9 for human and mouse genome UCSC version,
respectively. Orthologous promoter sequences of chimpanzee,
orangutan, and rhesus were obtained by blatting the 2.5-kb
human promoter sequences into the UCSC genome browser of
each species [70]. Rat promoter sequences were obtained by
blatting the 2.5-kb mouse promoter sequences into the UCSC
genome browser of rat. For each 2.5-kb promoter sequence,
PhastCons scores, Regulatory potential scores, CpG island, and
regions for repeated elements were also obtained through Table
Browser of the UCSC genome browser.
Genome-wide STAT3 ChIP-Seq data set was obtained from
[39]. In this data set, we first selected 461 genes with STAT3
binding peaks located in 2.5kb promoter regions, among which
412 genes have at least one site predicted by STAT-Scanner (cut-
off: 0.2) that is overlapped with experimentally identified regions
(within 150 bp of STAT3 binding peaks). We next defined true
positive sites as those that are overlapped with the STAT3 binding
regions and that match to the highest scoring site predicted by
STAT-Scanner, as suggested by [71].
Microarray data analysis
Cancer module map information was downloaded from the web
browser (http://ai.stanford.edu/,erans/cancer/). We used Can-
cer Module 3, 17, 18, 54, 57, 98, 124, 126, and 197, which contain
commonly up-regulated genes across liver cancer, B lymphoma,
grade3 breast cancer, and stimulated macrophages. Microarray
CEL data files of STAT3-C over-expressed cells were obtained
from Dr. E.B. Haura (University of South Florida, Tampa) [52].
Microarray data was analyzed using the SBEAMS program [72].
The data set was normalized by the global quantile scaling method
(GC-RMA) and filtered to include differentially expressed genes
with more than two fold change, with FDR ,0.1 and P-value
,0.01 (t-test).
Cell culture
Human hepatocarcinoma cell line, HepG2, was maintained in
MEM supplemented with 10% FBS (Hyclone, Logan, UT) and
1% penicillin/streptomycin (Invitrogen, Carlsbad, CA). Human
lung carcinoma cell line, A549, and breast cancer cell line, MDA-
MB-231, were cultured in DMEM with 10% FBS and 1%
penicillin/streptomycin. For IL-6 stimulation, cells were treated
with rhIL-6 (10 ng/ml) and rhIL-6sR (10 ng/ml) (R&D Systems,
Minneapolis, MN) for 15 minutes.
Chromatin Immunoprecipitation (ChIP)
ChIP assays were performed as described with minor changes
[64]. Cells were fixed in 1% formaldehyde for 15 min, harvested
in buffer A (0.25% Triton X-100, 10 mM EDTA, 0.5 mM
EGTA, 10 mM HEPES [pH 6.5]), and then resuspended in buffer
B (200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 10 mM
HEPES [pH 6.5]). Cells were then lysed in lysis buffer (1%
SDS, 10 mM EDTA, 50 mM Tris-HCl [pH 8.1] with proteinase
inhibitors). Chromatin sonication was performed three times for
40 s at setting 5.0 using a Branson 250 sonicator with a microtip.
Fragmented chromatin was immunoprecipitated with STAT3
antibodies (SC-482, SC-483; Santacruz Technology, CA, and
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After reversal of the cross-links and DNA precipitation, enriched
DNA was analyzed by PCR amplification with primers that flank
the predicted STAT3 TFBSs (Table S2).
Supporting Information
Figure S1 PWM similarity clustering. (A) Total 565 vertebrate
TRANSFAC PWMs were clustered by pair-wise similarity
comparison with the Kullback-Leibler divergence. The number
of PWM clusters at different similarity P-value cut-offs is plotted.
(B) PWM cluster at 10–7 P-value of similarity was represented by
Cytoscape [73]
Found at: doi:10.1371/journal.pone.0006911.s001 (1.55 MB TIF)
Figure S2 Quality scores of STAT-related PWMs and clustered
STAT-related PWMs in the known STAT3 TFBSs. (A) Histogram
of PWM quality score for all 565 vertebrate PWMs derived from
TRANSFAC ver. 9.4. (B) Number of STAT3 binding sites
detected by combined PWMs. Forty STAT3 TFBSs [35] were
used as reference dataset. (C) PWM quality score of STAT-related
PWMs.
Found at: doi:10.1371/journal.pone.0006911.s002 (0.96 MB TIF)
Figure S3 STAT3 TFBS prediction using MATCH and
MotifLocator. Curves for the changes of the number of true
positive TFBSs detected using MotifLocator (A) or MATCH (B) in
the reference set of 22 STAT3 target genes. PWM: V$STAT3_01,
V$STAT1_01, or combined PWMs of V$STAT3_01 and
V$STAT1_01 (All).
Found at: doi:10.1371/journal.pone.0006911.s003 (0.67 MB TIF)
Figure S4 Comparison of the TFBS prediction programs using
the genome-wide STAT3 binding. Curves for the changes of the
number of true positive TFBSs detected using MATCH (A) or
MotifLocator (B) in the genome-wide STAT3 ChIP-Seq dataset.
Found at: doi:10.1371/journal.pone.0006911.s004 (0.75 MB TIF)
Figure S5 Estimation of MCS confidence scores. The graph
displays confidence scores (dotted line) and predicted numbers of
conserved TFBSs (solid line) at each MCS cut-off value.
Found at: doi:10.1371/journal.pone.0006911.s005 (0.48 MB TIF)
Figure S6 Genome-wide distribution of predicted STAT3
TFBSs. Using 2.5-kb promoter sequences of all annotated human
reference genes, predicted STAT3 TFBSs with STAT-Scanner
(blue line at top, P-value ,0.1) or STAT-Finder (blue line at
bottom, posterior probability .0.5) were plotted. The red line
(random) shows the distribution of predicted TFBSs in the
randomly permutated promoter sequences.
Found at: doi:10.1371/journal.pone.0006911.s006 (0.80 MB TIF)
Figure S7 Experimental validation of STAT3 binding to the
novel STAT3 TFBS. The affinity score (top, STAT-Scanner) and
posterior probability (middle, STAT-Finder) of the predicted
STAT3 TFBS are plotted in the sliding windows for a 2.5-kb
promoter region across the ATF3 (A), DUSP5 (C), SERPINE1 (E),
NP (G), SLC2A3 (I), and CCL2 (K) genomic loci. The closed
square at bottom indicates predicted STAT3 TFBS with posterior
probability .0.5. (B, D, F, H, J, L) ChIP analysis with an anti-
STAT3 antibody.
Found at: doi:10.1371/journal.pone.0006911.s007 (7.45 MB TIF)
Figure S8 Performance comparison of the comparative align-
ment tools for the STAT3 target genes identified in this study.
Found at: doi:10.1371/journal.pone.0006911.s008 (0.36 MB TIF)
Table S1 Lists of the reference set for known STAT3 TFBSs.
Found at: doi:10.1371/journal.pone.0006911.s009 (0.17 MB
DOC)
Table S2 The information for primer sets used in ChIP
experiment.
Found at: doi:10.1371/journal.pone.0006911.s010 (0.04 MB
DOC)
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